Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives

The worldwide development of antimicrobial resistance forces scientists to search for new compounds to which microbes would be sensitive. Many new structures contain the 1,3,4-oxadiazole ring, which have shown various antimicrobial activity, e.g., antibacterial, antitubercular, antifungal, antiproto...

Descripción completa

Detalles Bibliográficos
Autores principales: Glomb, Teresa, Świątek, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268636/
https://www.ncbi.nlm.nih.gov/pubmed/34209520
http://dx.doi.org/10.3390/ijms22136979
_version_ 1783720401456594944
author Glomb, Teresa
Świątek, Piotr
author_facet Glomb, Teresa
Świątek, Piotr
author_sort Glomb, Teresa
collection PubMed
description The worldwide development of antimicrobial resistance forces scientists to search for new compounds to which microbes would be sensitive. Many new structures contain the 1,3,4-oxadiazole ring, which have shown various antimicrobial activity, e.g., antibacterial, antitubercular, antifungal, antiprotozoal and antiviral. In many publications, the activity of new compounds exceeds the activity of already known antibiotics and other antimicrobial agents, so their potential as new drugs is very promising. The review of active antimicrobial 1,3,4-oxadiazole derivatives is based on the literature from 2015 to 2021.
format Online
Article
Text
id pubmed-8268636
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82686362021-07-10 Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives Glomb, Teresa Świątek, Piotr Int J Mol Sci Review The worldwide development of antimicrobial resistance forces scientists to search for new compounds to which microbes would be sensitive. Many new structures contain the 1,3,4-oxadiazole ring, which have shown various antimicrobial activity, e.g., antibacterial, antitubercular, antifungal, antiprotozoal and antiviral. In many publications, the activity of new compounds exceeds the activity of already known antibiotics and other antimicrobial agents, so their potential as new drugs is very promising. The review of active antimicrobial 1,3,4-oxadiazole derivatives is based on the literature from 2015 to 2021. MDPI 2021-06-29 /pmc/articles/PMC8268636/ /pubmed/34209520 http://dx.doi.org/10.3390/ijms22136979 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Glomb, Teresa
Świątek, Piotr
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title_full Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title_fullStr Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title_full_unstemmed Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title_short Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives
title_sort antimicrobial activity of 1,3,4-oxadiazole derivatives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268636/
https://www.ncbi.nlm.nih.gov/pubmed/34209520
http://dx.doi.org/10.3390/ijms22136979
work_keys_str_mv AT glombteresa antimicrobialactivityof134oxadiazolederivatives
AT swiatekpiotr antimicrobialactivityof134oxadiazolederivatives

Ejemplares similares